Signal2026-07-30
ClinicalTrials.gov

[PHASE1] A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture